Adjuvant FOLFIRI with or without cetuximab in patients with resected stage III colon cancer: NCCTG Intergroup phase III trial N0147
- Citation:
- J Cin Oncol 29, No 4_suppl (February vol 29 (4s) abstr 363
- Meeting Instance:
- ASCO GI 2011
- Year:
- 2011
- Type:
- Abstract
- Sub type:
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- ppub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Parents:
- None
- Children:
- 477
- Pharmas:
- Grants:
- Corr. Author:
- Authors:
- J. Huang D. J. Sargent M. R. Mahoney S. N. Thibodeau T. C. Smyrk F. Sinicrope G. D. Alberts S. R. Nelson
- Networks:
- Study
- NCCTG-N0147
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords: